Lista de obras - Rebecca Schweppe - Dominio Público Uruguay

Characterization of thyroid cancer cell lines in murine orthotopic and intracardiac metastasis models

artículo científico publicado en 2015

Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies

artículo científico publicado en 2019

Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cells.

artículo científico publicado en 2009

Development and characterization of six new human papillary thyroid carcinoma cell lines.

artículo científico publicado en 2014

Development of new preclinical models to advance adrenocortical carcinoma research

artículo científico publicado en 2018

Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers

scientific article published on 07 February 2019

FAK Expression, Not Kinase Activity, Is a Key Mediator of Thyroid Tumorigenesis and Protumorigenic Processes.

artículo científico publicado en 2016

Fibronectin Contributes to a BRAF Inhibitor–driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2

scientific article published in 2023

Functional components of fibroblast growth factor (FGF) signal transduction in pituitary cells. Identification of FGF response elements in the prolactin gene.

artículo científico publicado en 1997

Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanoma

artículo científico publicado en 2009

Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers.

artículo científico publicado en 2018

Global gene expression analysis of ERK5 and ERK1/2 signaling reveals a role for HIF-1 in ERK5-mediated responses.

artículo científico publicado en 2006

Hypofractionated Radiotherapy Is Superior to Conventional Fractionation in an Orthotopic Model of Anaplastic Thyroid Cancer.

artículo científico publicado en 2018

Inhibition of Src with AZD0530 reveals the Src-Focal Adhesion kinase complex as a novel therapeutic target in papillary and anaplastic thyroid cancer.

artículo científico publicado en 2009

Inhibition of nuclear factor-kappa B differentially affects thyroid cancer cell growth, apoptosis, and invasion.

artículo científico publicado en 2010

Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studies.

artículo científico publicado en 2016

Monitoring post-translational modification of proteins with allosteric ribozymes

artículo científico publicado en 2002

Nuclear factor κB-dependent regulation of angiogenesis, and metastasis in an in vivo model of thyroid cancer is associated with secreted interleukin-8.

artículo científico publicado en 2014

PPARγ Promotes Growth and Invasion of Thyroid Cancer Cells

artículo científico publicado en 2011

Research ethics dilemmas in thyroid disease

artículo científico publicado en 2018

Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis

artículo científico publicado en 2018

Src-mediated regulation of the PI3K pathway in advanced papillary and anaplastic thyroid cancer.

artículo científico publicado en 2018

Sustained activation of the AKT/mTOR and MAP kinase pathways mediate resistance to the Src inhibitor, dasatinib, in thyroid cancer.

artículo científico publicado en 2017

Targeted inhibition of Src kinase with dasatinib blocks thyroid cancer growth and metastasis.

artículo científico publicado en 2012

The Mitogen-Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor Dasatinib in Thyroid Cancer.

artículo científico publicado en 2016

The characterization of protein post-translational modifications by mass spectrometry

artículo científico publicado en 2003

Thyroid cancer cell line misidentification: an update.

artículo científico publicado en 2013

Thyroid cancer cell lines: Critical models to study thyroid cancer biology and new therapeutic targets ⬇️

artículo científico publicado el 19 de junio de 2012

Thyroid targeted Kras(G12D)/Pten(-/-) mice and their cell lines: new tools to study thyroid cancer biology

artículo científico publicado en 2011

Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells

artículo científico publicado en 2015

mTOR Inhibition promotes TTF1-dependent redifferentiation and restores iodine uptake in thyroid carcinoma cell lines

artículo científico publicado en 2014

Lista de obras de Rebecca Schweppe

Characterization of thyroid cancer cell lines in murine orthotopic and intracardiac metastasis models

Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies

Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cells.

Development and characterization of six new human papillary thyroid carcinoma cell lines.

Development of new preclinical models to advance adrenocortical carcinoma research

Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers

FAK Expression, Not Kinase Activity, Is a Key Mediator of Thyroid Tumorigenesis and Protumorigenic Processes.

Fibronectin Contributes to a BRAF Inhibitor–driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2

Functional components of fibroblast growth factor (FGF) signal transduction in pituitary cells. Identification of FGF response elements in the prolactin gene.

Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanoma

Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers.

Global gene expression analysis of ERK5 and ERK1/2 signaling reveals a role for HIF-1 in ERK5-mediated responses.

Hypofractionated Radiotherapy Is Superior to Conventional Fractionation in an Orthotopic Model of Anaplastic Thyroid Cancer.

Inhibition of Src with AZD0530 reveals the Src-Focal Adhesion kinase complex as a novel therapeutic target in papillary and anaplastic thyroid cancer.

Inhibition of nuclear factor-kappa B differentially affects thyroid cancer cell growth, apoptosis, and invasion.

Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studies.

Monitoring post-translational modification of proteins with allosteric ribozymes

Nuclear factor κB-dependent regulation of angiogenesis, and metastasis in an in vivo model of thyroid cancer is associated with secreted interleukin-8.

PPARγ Promotes Growth and Invasion of Thyroid Cancer Cells

Research ethics dilemmas in thyroid disease

Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis

Src-mediated regulation of the PI3K pathway in advanced papillary and anaplastic thyroid cancer.

Sustained activation of the AKT/mTOR and MAP kinase pathways mediate resistance to the Src inhibitor, dasatinib, in thyroid cancer.

Targeted inhibition of Src kinase with dasatinib blocks thyroid cancer growth and metastasis.

The Mitogen-Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor Dasatinib in Thyroid Cancer.

The characterization of protein post-translational modifications by mass spectrometry

Thyroid cancer cell line misidentification: an update.

Thyroid cancer cell lines: Critical models to study thyroid cancer biology and new therapeutic targets ⬇️

Thyroid targeted Kras(G12D)/Pten(-/-) mice and their cell lines: new tools to study thyroid cancer biology

Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells

mTOR Inhibition promotes TTF1-dependent redifferentiation and restores iodine uptake in thyroid carcinoma cell lines